Evaluation of Schedule of bile replacement for obstructive jaundice

Evaluation of Schedule of bile replacement for obstructive jaundice - Evaluation of Schedule of bile replacement

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006645

Enrollment

Registered

2011-11-01

Start date

2011-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Biliary tract cancer and pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Performance Status 0 or 1 Patients over 20 years of age to 80 years Pancreaticobiliary tract cancer patients without multiple organ failure Patients with serum total bilirubin levels greater than 5.0mg/dl, direct bilirubin levels greater than 3.0mg/dl

Exclusion criteria

Exclusion criteria: Patients who do not agree this study Patients deemed inappropriate by the attending physician

Design outcomes

Primary

Measure	Time frame
peripheral blood, coagulation, liver function, concanavaline A, PHA, VitaminK	—

Secondary

Measure	Time frame
Diamine oxydase, fatty acid	—

Countries

Japan

Contacts

Public ContactUeno Kimihiko

Kobe University hepatobiliary pancreatic surgery

kueno@kobeh.rofuku.go.jp078-382-6302

Outcome results